Premium
Basal cell carcinoma and actinic keratoses: patients' perceptions of their disease and current treatments
Author(s) -
Berman Brian
Publication year - 2001
Publication title -
international journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 93
eISSN - 1365-4632
pISSN - 0011-9059
DOI - 10.1046/j.1365-4362.2001.01280.x
Subject(s) - medicine , basal cell carcinoma , actinic keratoses , skin cancer , dermatology , incidence (geometry) , basal cell , actinic keratosis , carcinoma , cancer , photodermatosis , xeroderma pigmentosum , dna , physics , genetics , biology , optics , dna damage
Background The increasing incidence of nonmelanoma skin cancer constitutes a significant worldwide epidemic. Chronic exposure to ultraviolet light is the predominant risk factor for basal cell carcinoma (BCC), which will make up approximately 80% of new cases of skin cancer per year, and for actinic keratoses (AK), an early manifestation of squamous cell carcinoma. BCC and AK are associated with considerable morbidity, which can be decreased if detected and treated early. Methods Patients in the United States (US), Australia, Spain and Germany took part in discussion groups in which they were asked about their knowledge of BCC or AK and current diagnosis and treatment processes. Results In this study, patients were found to have only a basic understanding of BCC or AK, and furthermore, they were not satisfied with the amount of information provided by their physician about their treatment options, and possible side‐effects such as pain and scarring . Conclusions Increased public awareness about BCC and AK may potentially aid in their early detection and treatment.